The European Union will seek to diversify its supply chains to cut reliance on other nations for crucial assets such as medicines, even as it works to strengthen trade ties with India, the bloc’s top diplomat says.
The LogiMed Virtual Event will provide you with insights and resources from your peers who are also working through unprecedented challenges at their organizations.
Claudia Lewis, partner with Venable LLP, describes how the U.S. Food and Drug Administration is revising its policies, practices and regulations in response to the coronavirus pandemic.
Trade talks between the EU and U.K. have struggled in recent weeks, increasing the prospect that Britain departs the bloc without a deal and that businesses face an extreme shock when the divorce takes effect.
The trade war amplified calls in the U.S. and elsewhere for reducing dependence on China for strategic goods. Now, the pandemic has politicians vowing to take action.
Christopher Tang, professor at UCLA's Anderson School of Management, describes what it will take for hospital and healthcare supply chains to recover from the COVID-19 pandemic.
The Food and Drug Administration had to walk back testimony by an official at a Senate hearing last week after he downplayed the scale of China’s dominance of the drug supply chain in the U.S.
The latest supply-chain news, analysis, trends and tools for executives in the pharmaceutical and biotech industries. Learn how pharmaceutical and biotech companies and their suppliers around the world are managing the flow of products across all channels of the enterprise. Experts sound off on forecasting and demand planning, supply-chain visibility, logistics outsourcing, inventory optimization, transportation management, warehouse management, supply-chain security, corporate social responsibility and more.
Subscribe to our Daily Newsletter!
Timely, incisive articles delivered directly to your inbox.